Skip to content
777 Sourcing.

Capability

oral mRNA vaccine platform development

Suppliers
1
States & provinces
1
Countries
1

1 oral mrna vaccine platform development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ESPEROVAX INC

PLYMOUTH, MI

Esperovax is a biotechnology company based in Plymouth, Michigan, founded in 2019 to advance development of its Egress RD™ oral mRNA platform, a technology for delivering mRNA vaccines to immune cells in the gastrointestinal tract via a small oral capsule. The company develops proprietary oral mRNA vaccines and biotherapeutics intended to be safe, stable at room temperature, and produced at lower cost than traditional injectables.

continuous purification processvaccine and therapeutics developmentvirus-like particle (VLP) productionyeast-based manufacturing

Compiled from public sources

Related capabilities

Other processes offered by the shops that list oral mRNA vaccine platform development.

Browse all capabilities